Cnbx Pharmaceuticals Inc (CNBK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CNBK Annual Balance Sheets →
Quarterly balance sheet trends provide context on Cnbx Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(May 31 2026)
(Feb 28 2026) (Nov 30 2025) (Aug 31 2025) (May 31 2025)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.00
Total Current Assets0.01
Other Assets, Noncurrent0.00
Total Assets0.01
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.05
Accrued Liabilities, Current0.19
Short-term Debt DE10.12
Other Liabilities, Current2.32
Total Current Liabilities2.67
Total Long-term Debt0.00
Due To A Related Party Current1.34
Total Liabilities2.67
Stockholders' Equity
Common Stock Value0.15
Additional Paid In Capital Common Stock22.77
Retained Earnings / Accumulated Deficit-25.58
Other Equity0.00
Common Stockholder's Equity-2.66
Total Stockholder's Equity-2.66
Liabilities & Stockholder's Equity0.01
4 historic quarters locked

Sign in to unlock the full Cnbx Pharmaceuticals Inc balance sheet history.

About Cnbx Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-005078

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.